Viewing Study NCT02637804


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2026-01-04 @ 10:52 AM
Study NCT ID: NCT02637804
Status: COMPLETED
Last Update Posted: 2017-10-23
First Post: 2015-12-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Daily Disposable Silicone Hydrogel Contact Lens, Stenfilcon A, Clinical Study
Sponsor: CooperVision, Inc.
Organization:

Study Overview

Official Title: Daily Disposable Silicone Hydrogel Contact Lens, Stenfilcon A, Clinical Study
Status: COMPLETED
Status Verified Date: 2017-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Clinical evaluation of stenfilcon A compared with narafilcon A and delefilcon A

This is a total 120 subject, randomized, open label, bilateral wear, two week crossover study (each lens for 1 week) evaluating the clinical performance of stenfilcon A spherical lenses compared to narafilcon A or delefilcon A spherical lenses.
Detailed Description: The aim of this study is to evaluate the clinical performance of stenfilcon A compared with narafilcon A and delefilcon A.

The study participants will be allocated to two parallel groups (Group 1 and Group 2), 60 subjects each, based on the control lenses, narafilcon A and delefilcon A spherical lenses.

Study groups:

Group 1: stenfilcon A vs. narafilcon A

Group 2: stenfilcon A vs. delefilcon A

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: